Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.40 |
| ▸ | LGALS8 | O00214 | 5/20 | 0.38 |
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.36 |
| ▸ | CD69 | Q07108 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.33 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1614945 | 0.93 | LDHA (0.44) | CDK1CCNB1LGALS8LDHAEPHX2 | |
| SCHEMBL13297613 | 0.92 | CYP2D6 (0.41) | CDK1CCNB1LDHAEPHX2CA2 | |
| SCHEMBL14435948 | 0.92 | CYP2D6 (0.41) | CDK1CCNB1LDHAEPHX2CA2 | |
| SCHEMBL2888522 | 0.90 | CYP2D6 (0.39) | CDK1CCNB1LDHAEPHX2CD69 | |
| SCHEMBL13777015 | 0.90 | CYP2D6 (0.39) | CDK1CCNB1LDHAEPHX2CD69 | |
| SCHEMBL14435952 | 0.90 | CYP2D6 (0.39) | CDK1CCNB1LDHAEPHX2CD69 | |
| SCHEMBL13297616 | 0.90 | CYP2D6 (0.39) | CDK1CCNB1LDHAEPHX2CD69 | |
| SCHEMBL742761 | 0.86 | LGALS8 (0.38) | CDK1CCNB1LGALS8LDHAEPHX2 | |
| SCHEMBL4581260 | 0.85 | CYP2D6 (0.41) | CDK1CCNB1LGALS8LDHAEPHX2 | |
| Lindane SCHEMBL16818405 | 0.82 | LDHA (0.43) | CDK1CCNB1LGALS8LDHAEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023166943-A1 | RESIN COMPOSITION, APPLICATION THEREOF, AND MOLDING METHOD THEREFOR | 大阪ガスケミカル株式会社 | 2023-09-07 | — | — | WO | disclosed |
| EP-1948571-B1 | SURFACE TREATMENT OF GLASS SHEETS PRIOR TO STORAGE | PILKINGTON GROUP LTD (GB) | 2010-01-20 | — | — | EP | disclosed |
| US-20100009202-A1 | Surface Treatment of Glass Sheets Prior to Storage | PILKINGTON GROUP LIMITED (GB) | 2010-01-14 | — | — | US | disclosed |
| EP-1948571-A1 | SURFACE TREATMENT OF GLASS SHEETS PRIOR TO STORAGE | Pilkington Group Limited (GB) | 2008-07-30 | — | — | EP | disclosed |
| WO-2007052028-A1 | SURFACE TREATMENT OF GLASS SHEETS PRIOR TO STORAGE | PILKINGTON GROUP LIMITED (GB) | 2007-05-10 | — | — | WO | disclosed |
| WO-1992017214-A2 | PHYSICALLY AND CHEMICALLY STABILIZED POLYATOMIC CLUSTERS FOR MAGNETIC RESONANCE IMAGE AND SPECTRAL ENHANCEMENT | RANNEY DAVID F (US) | 1992-10-15 | — | — | WO | disclosed |
| EP-0260979-B1 | SUCROSE DERIVATIVES | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1991-05-15 | — | — | EP | disclosed |
| EP-0260979-A2 | Sucrose derivatives | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1988-03-23 | — | — | EP | disclosed |
| US-4306062-A | TRANSESTERIFICATION WITH AN ALKENYL ESTER OF A FATTY ACID | TALRES DEVELOPMENT (N.A.) N.V. (AN) | 1981-12-15 | — | — | US | disclosed |
| EP-0020122-A1 | Process for the preparation of sucrose monoesters | TATE & LYLE PATENT HOLDINGS LIMITED (BM) | 1980-12-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009202-A1 | Surface Treatment of Glass Sheets Prior to Storage | GANAB, GAA, GLA | CDK1 3659/4885CCNB1 3200/4885LGALS8 293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.